1357362-70-9Relevant academic research and scientific papers
NOSH-aspirin: A novel nitric oxide-hydrogen sulfide-releasing hybrid: A new class of anti-inflammatory pharmaceuticals
Kodela, Ravinder,Chattopadhyay, Mitali,Kashfi, Khosrow
, p. 257 - 262 (2012)
A series of new hybrids of aspirin (ASA), bearing both nitric oxide (NO) and hydrogen sulfide (H2S)-releasing moieties were synthesized and designated as NOSH compounds (1-4). NOSH-1 (4-(3-thioxo-3H-1,2-dithiol-5-yl) phenyl 2-((4-(nitrooxy)buta
NO- AND H2S- RELEASING COMPOUNDS
-
Paragraph 0065-0067, (2016/10/11)
This disclosure relates to novel compounds containing an H2S releasing moiety and a nitric oxide (NO) releasing moiety covalently linked with a core (e.g., a salicylic acid moiety) and the use of such compounds in treating inflammatory diseases, including
NO- AND H2S- RELEASING COMPOUNDS
-
Page/Page column 85, (2013/03/26)
This disclosure relates to compounds containing both an NO-releasing moiety and an H2S-releasing moiety and the use of such compounds in treating inflammatory diseases, including cancers.
